A new treatment for dry eye in people with diabetes
Treatments studied
Part of Eyes & vision clinical trials.
This study tests a new eye drop treatment for people with diabetes who also have dry eye disease. The treatment is designed to target the root cause of dry eye in diabetes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have diabetes (blood sugar higher than normal).
- You have had dry eye symptoms in both eyes for at least 6 months.
- You are currently using artificial tears for dry eye.
- You have not had eye surgery or laser treatment in the last 6 months.
- You are willing to use birth control during the trial (if you can have children).
- You have no other active eye conditions that could affect the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new approach aimed at improving diabetic eye disease (diabetic retinopathy). It may help by changing inflammation and related processes in the eye, especially in people who have diabetes and eye changes.
This study tests whether an experimental eye drop can slow or treat early-stage diabetic retinopathy. If you have diabetes-related vision changes, this treatment might help prevent the condition from getting worse.
This study tests whether insulin eye drops can safely help dry eye in people who also use eye drops for glaucoma. It may offer a new option if you have both conditions and your eye pressure is stable.
This trial tests a new eye drop called DFL24498 to see if it helps people with dry eye disease. You may qualify if your dry eye is moderate to severe and other treatments haven't worked well for you.
This study looks at whether people with diabetes who have a certain eye condition called diabetic macular edema (swelling in the back of the eye) also have more dry eye problems. It may help doctors understand the link and improve care for both conditions.
This is an early-stage safety study testing a new medicine injected directly into the eye to treat diabetic retinopathy (damage to blood vessels in the retina caused by diabetes). The study checks if the medicine is safe and how the body processes it.
Hear when a new Diabetic Keratopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.